[go: up one dir, main page]

DE60119919D1 - Freie aminosäure enthaltende zusammensetzung - Google Patents

Freie aminosäure enthaltende zusammensetzung

Info

Publication number
DE60119919D1
DE60119919D1 DE60119919T DE60119919T DE60119919D1 DE 60119919 D1 DE60119919 D1 DE 60119919D1 DE 60119919 T DE60119919 T DE 60119919T DE 60119919 T DE60119919 T DE 60119919T DE 60119919 D1 DE60119919 D1 DE 60119919D1
Authority
DE
Germany
Prior art keywords
aminoic
free
composition
administering
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60119919T
Other languages
English (en)
Other versions
DE60119919T2 (de
Inventor
Constance Whippie
Olivier Ballevre
Julio Boza
Paul-Andre Finot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of DE60119919D1 publication Critical patent/DE60119919D1/de
Publication of DE60119919T2 publication Critical patent/DE60119919T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE60119919T 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung Expired - Lifetime DE60119919T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0009056 2000-04-12
GBGB0009056.3A GB0009056D0 (en) 2000-04-12 2000-04-12 Composition comprising free amino acids
PCT/EP2001/003188 WO2001078532A1 (en) 2000-04-12 2001-03-21 Composition comprising free amino acids

Publications (2)

Publication Number Publication Date
DE60119919D1 true DE60119919D1 (de) 2006-06-29
DE60119919T2 DE60119919T2 (de) 2007-04-26

Family

ID=9889802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60119919T Expired - Lifetime DE60119919T2 (de) 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung

Country Status (17)

Country Link
US (3) US20040096478A1 (de)
EP (1) EP1274322B1 (de)
JP (1) JP5600232B2 (de)
KR (1) KR20020089448A (de)
CN (1) CN1243542C (de)
AT (1) ATE326867T1 (de)
CA (1) CA2404005C (de)
DE (1) DE60119919T2 (de)
ES (1) ES2263602T3 (de)
GB (1) GB0009056D0 (de)
HK (1) HK1054489A1 (de)
HU (1) HUP0300299A3 (de)
MX (1) MXPA02010058A (de)
NO (1) NO324525B1 (de)
PL (1) PL358876A1 (de)
RU (1) RU2002130204A (de)
WO (1) WO2001078532A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
US6592908B1 (en) * 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
ES2391558T3 (es) 2003-06-23 2012-11-27 Nestec S.A. Suplemento de aminoácidos para un ecosistema microbiótico sano
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
ES2550608T3 (es) * 2003-12-20 2015-11-11 Nestec S.A. Composición nutritiva para la curación de las heridas
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
EP1767201B8 (de) 2004-06-28 2012-02-29 Ajinomoto Co., Inc. Nährstoffzusammensetzung und zusammensetzung zur prävention/mitigation von verdauungstraktdepression
EP2305241A1 (de) * 2004-09-17 2011-04-06 Ajinomoto Co., Inc. Verwendung von einem 5'-Nucleotid zur Prävention/Verbesserung von funktionalen Verdauungsstörungen
US20090209647A1 (en) * 2005-06-14 2009-08-20 Nestec S.A. Nutritional method
JPWO2007004613A1 (ja) * 2005-07-01 2009-01-29 味の素株式会社 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
JP4916143B2 (ja) * 2005-08-04 2012-04-11 サッポロビール株式会社 ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物
EP1946764A4 (de) 2005-08-29 2009-08-26 Ajinomoto Kk Nährstoffzusammensetzung
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
WO2009113594A1 (ja) * 2008-03-11 2009-09-17 味の素株式会社 機能性消化管障害予防・改善剤および食品
WO2011021926A1 (en) * 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
JP2013511983A (ja) * 2009-11-25 2013-04-11 ネステク ソシエテ アノニム 高タンパク成分及び外因性ヌクレオチドを含む栄養組成物
JP2011121887A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121888A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
US8993522B2 (en) * 2010-09-24 2015-03-31 University Of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2968241B1 (de) 2013-03-11 2018-10-31 University of Florida Research Foundation, Inc. Materialien und verfahren zur verbesserung der lungenfunktion und zur vorbeugung und/oder behandlung von strahlungsinduzierten lungenkomplikationen
WO2015108157A1 (ja) * 2014-01-17 2015-07-23 株式会社明治 食後早期飽満感または胃食道逆流症の予防または改善剤
WO2015167002A1 (ja) * 2014-04-30 2015-11-05 味の素株式会社 消化管障害を改善する組成物
MX2017006748A (es) 2014-11-24 2017-08-28 Entrinsic Health Solutions Inc Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
ES2779749T3 (es) * 2015-05-14 2020-08-19 Professional Dietetics Int Srl Composiciones que comprenden aminoácidos para uso en el tratamiento de mucositis en pacientes con neoplasia que están sometidos a radioterapia y/o quimioterapia
BR112017026185A2 (pt) * 2015-06-10 2018-08-14 Ajinomoto Kk agente e método para melhorar um distúrbio gastrointestinal induzido por exercício.
MA43271A (fr) 2015-06-17 2018-09-26 Dispersol Technologies Llc Formulations améliorées de déférasirox et leurs procédés de fabrication
CN105747214A (zh) * 2016-02-26 2016-07-13 四川安益生物科技有限公司 一种支链氨基酸组合物
JP7267546B2 (ja) 2016-10-04 2023-05-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド アミノ酸組成物及びその使用
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
DE102017201713A1 (de) 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
WO2018200477A1 (en) * 2017-04-25 2018-11-01 Almeda Labs Llc Amino acid formulations for pancreatic viability
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
JP2019058140A (ja) * 2017-09-27 2019-04-18 味の素株式会社 栄養組成物
TW201932483A (zh) * 2018-01-16 2019-08-16 林文欽 用於形成膠原蛋白的氨基酸組成物
EP3810123A1 (de) 2018-06-20 2021-04-28 Axcella Health Inc. Zusammensetzungen und verfahren zur behandlung von fettinfiltration in muskeln
KR20220006103A (ko) * 2019-05-08 2022-01-14 마이코테크놀로지, 인코포레이티드 균사체 증량 조성물의 제조 방법
CN111067885A (zh) * 2020-02-20 2020-04-28 杨益文 一种消除幽门螺旋螺杆菌及治疗胃及十二指肠溃疡的药物
WO2021178860A1 (en) * 2020-03-06 2021-09-10 Axcella Health Inc. Amino acid compositions and methods for muscle and myotube modulation
KR20230019151A (ko) * 2020-06-02 2023-02-07 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 설사를 치료하기 위한 제형 및 방법
WO2023066831A1 (en) * 2021-10-21 2023-04-27 Société des Produits Nestlé S.A. Composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT945910B (it) * 1971-04-08 1973-05-10 Erra C Spa Prodotto dietetico impiegabile quale intergratore dell alimenta zione umana con particolare riferi mento all infanzia agli stati di convalescenza di gravidanza d allat tamento e dell eta senile e procedi mento per la sua fabbricazione
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
GB2223925A (en) * 1988-09-09 1990-04-25 Stiff John Edward Dietary supplements
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5106836A (en) * 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
RU2080871C1 (ru) * 1994-05-30 1997-06-10 Макаров Николай Васильевич Средство, обладающее регенеративной активностью
RU2091067C1 (ru) * 1994-05-30 1997-09-27 Мыслицкая Людмила Николаевна Способ лечения желудочно-кишечных заболеваний
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
EP1123013A1 (de) 1997-06-02 2001-08-16 Société des Produits Nestlé S.A. Produkt und verfahren zur versehung von glutamine
WO1999013738A1 (en) 1997-09-16 1999-03-25 Societe Des Produits Nestle S.A. Organ specific nutrition

Also Published As

Publication number Publication date
US20060247312A1 (en) 2006-11-02
EP1274322B1 (de) 2006-05-24
US8383680B2 (en) 2013-02-26
US20040096478A1 (en) 2004-05-20
DE60119919T2 (de) 2007-04-26
HUP0300299A2 (hu) 2003-07-28
US20120035234A1 (en) 2012-02-09
NO324525B1 (no) 2007-11-12
ES2263602T3 (es) 2006-12-16
US8067471B2 (en) 2011-11-29
JP2003530411A (ja) 2003-10-14
HK1054489A1 (zh) 2003-12-05
CA2404005C (en) 2009-12-08
WO2001078532A1 (en) 2001-10-25
NO20024743L (no) 2002-12-03
GB0009056D0 (en) 2000-05-31
MXPA02010058A (es) 2003-03-10
JP5600232B2 (ja) 2014-10-01
KR20020089448A (ko) 2002-11-29
NO20024743D0 (no) 2002-10-02
CN1243542C (zh) 2006-03-01
PL358876A1 (en) 2004-08-23
RU2002130204A (ru) 2004-03-27
ATE326867T1 (de) 2006-06-15
HUP0300299A3 (en) 2005-01-28
CN1422125A (zh) 2003-06-04
EP1274322A1 (de) 2003-01-15
CA2404005A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
DE60119919D1 (de) Freie aminosäure enthaltende zusammensetzung
CA2219502A1 (en) Methods and formulations for modulating the human sexual response
HUP9701540A1 (hu) A gasztrointesztinális keringést elősegítő gyógyászati készítmény
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
NO990279D0 (no) Isobutylgaba og dets derivater for behandling av smerte
EP0637239A4 (de) Verfahren zur förderung der stickstoffzurückhaltung beim menschen.
DK1137762T3 (da) Behandling af Pompes sygdom
DE122006000051I2 (de) Ester der 5-Aminolevulinsäure als Mittel zur Photosensibilisierung in der Chemotherapie
HUP0400732A2 (hu) Gyógyászatilag hatékony uridin-észterek
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
PT998287E (pt) Utilizacao de levobupivacaina
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
AU1870397A (en) Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
FR2618439B1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
MD1469G2 (ro) Metodă de tratament al şocului combustional
MY117556A (en) Methods and formulations for modulating the human sexual response
UA38388A (uk) Спосіб лікування епідемічного паротиту
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу

Legal Events

Date Code Title Description
8364 No opposition during term of opposition